Previous studies reported that Akt is a desirable target in MM, a locus and fragility of cancer multidrug resistance.27,34 We further examined whether the expression of pAkt was altered in the CIP2A-depleted MM.1R cells. The gene discussed is AKT1; the disease is Miyoshi myopathy.